Trials / Unknown
UnknownNCT00742066
Role of AT1-receptor Blockers in Insulin-induced Vasodilation.
Insulin-induced Microvascular Activity in Patients With Essential Hypertension: a Possible Role for Angiotensin II AT1-receptor Blockers.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
In this study we hypothesize that blocking the angiotensin II AT1-receptor improves the insulin-induced microvascular dilatation. Objectives: 1. Does blockade of the angiotensin II AT1-receptor improve the insulin-induced microvascular effects in hypertensive patients. 2. Does blockade of the angiotensin II AT1-receptor impair the insulin-induced microvascular effects in normotensive control subjects?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Irbesartan | Single dose 600mg orally |
| DRUG | Felodipine | single dose 10mg Felodipine ER |
| DRUG | Placebo | Single dose tablet orally |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2008-08-27
- Last updated
- 2011-03-17
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00742066. Inclusion in this directory is not an endorsement.